Παρακολούθηση
Eleftherios Pelechas
Eleftherios Pelechas
University Hospital of Ioannina
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα doctors.org.uk - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Treatment strategies are more important than drugs in the management of rheumatoid arthritis
AA Drosos, E Pelechas, PV Voulgari
Clinical Rheumatology 39 (4), 1363-1368, 2020
562020
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk
AI Venetsanopoulou, E Pelechas, PV Voulgari, AA Drosos
Rheumatology international 40 (8), 1181-1191, 2020
482020
Golimumab for rheumatoid arthritis
E Pelechas, PV Voulgari, AA Drosos
Journal of Clinical Medicine 8 (3), 387, 2019
462019
Spinal Cord Stimulation in Refractory Angina. A systematic review of randomized controlled trials.
N Tsigaridas, K Naka, P Tsapogas, E Pelechas, D Damigos
Acta Cardiologica 70 (2), 233-243, 2015
382015
A comparative study of job satisfaction of the medical and nursing staff in two regional hospitals in Greece.
E Pelechas, A Antoniadis
Archives of Hellenic Medicine/Arheia Ellenikes Iatrikes 30 (3), 2013
36*2013
Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center
E Kaltsonoudis, E Pelechas, PV Voulgari, AA Drosos
Seminars in arthritis and rheumatism 48 (4), 597-602, 2019
352019
Rheumatoid arthritis treatment. A back to the drawing board project or high expectations for low unmet needs?
AA Drosos, E Pelechas, PV Voulgari
Journal of Clinical Medicine 8 (8), 1237, 2019
272019
Sirukumab: a promising therapy for rheumatoid arthritis
E Pelechas, PV Voulgari, AA Drosos
Expert opinion on biological therapy 17 (6), 755-763, 2017
262017
Etanercept biosimilar SB-4
E Pelechas, AA Drosos
Expert Opinion on Biological Therapy 19 (3), 173-179, 2019
252019
Comment on: Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry
E Kaltsonoudis, E Pelechas, PV Voulgari, AA Drosos
Rheumatology 58 (10), 1883-1884, 2019
24*2019
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus
F Ingegnoli, AL Herrick, T Schioppo, F Bartoli, N Ughi, JD Pauling, A Sulli, ...
Rheumatology 60 (3), 1410-1418, 2021
232021
Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings
AA Drosos, E Pelechas, PV Voulgari
Rheumatology international 39 (8), 1331-1341, 2019
222019
Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study
GK Tsirves, PV Voulgari, E Pelechas, AD Asimakopoulos, AA Drosos
European Archives of Oto-Rhino-Laryngology 276, 2419-2426, 2019
212019
Colchicine against SARS-CoV-2 infection: what is the evidence?
AA Drosos, E Pelechas, V Drossou, PV Voulgari
Rheumatology and therapy 9 (2), 379-389, 2022
202022
Therapeutic options and cost-effectiveness for rheumatoid arthritis treatment
AA Drosos, E Pelechas, E Kaltsonoudis, PV Voulgari
Current rheumatology reports 22 (8), 44, 2020
192020
Illustrated handbook of rheumatic and musculo-skeletal diseases
E Pelechas, E Kaltsonoudis, PV Voulgari, AA Drosos
Springer International Publishing, 2019
17*2019
ABP 501 for the treatment of rheumatoid arthritis
E Pelechas, PV Voulgari, AA Drosos
Expert Opinion on Biological Therapy 18 (3), 317-322, 2018
172018
Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
E Pelechas, PV Voulgari, AA Drosos
Ther Clin Risk Man 2019 (15), 1073-1079, 2019
162019
Anti-rheumatic drugs for the fight against the novel coronavirus infection (Sarscov-2): what is the evidence?
E Pelechas, V Drossou, PV Voulgari, AA Drosos
Mediterranean Journal of Rheumatology 31 (Suppl 2), 259, 2020
142020
Maintained clinical remission in ankylosing spondylitis patients switched from reference infliximab to its biosimilar: an 18-month comparative open-label study
E Kaltsonoudis, E Pelechas, PV Voulgari, AA Drosos
Journal of Clinical Medicine 8 (7), 956, 2019
142019
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20